Login / Signup

An Australian mainstream genetic testing program: Clinicians views about current and future practices.

Alison Luk YoungEmilia IpTahlia ScheinbergMichelle HarrisonPhilip BealeAnnabel Goodwin
Published in: Asia-Pacific journal of clinical oncology (2023)
From the clinician's perspective, the mainstreaming program is considered a desirable pathway for germline testing of oncology patients. Access to ongoing education and resources is needed for the ongoing success of the program.
Keyphrases
  • quality improvement
  • end stage renal disease
  • healthcare
  • palliative care
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • primary care
  • peritoneal dialysis
  • dna repair
  • patient reported outcomes